We are live on ! Find out more
FNCH

Finch Therapeutics Group, Inc. Common Stock
FNCH

Delisted

FNCH was delisted on the 24th of May, 2024.

Back to rankings

36 hedge funds and large institutions have $109M invested in Finch Therapeutics Group, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 36 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
+36
Holders Change %
–
% of All Funds
0.63%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
36
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
+$20.5M
2
BL
Bleichroeder LP
New York
+$13.8M
3
Bank of America
Bank of America
North Carolina
+$12.2M
4
TA
TRB Advisors
New York
+$9.34M
5
AI
Aperture Investors
New York
+$7.97M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BG
1
Baupost Group
Massachusetts
$18.9M +$20.5M +40,272 New
BL
2
Bleichroeder LP
New York
$13.1M +$13.8M +27,014 New
Bank of America
3
Bank of America
North Carolina
$11.6M +$12.2M +23,973 New
TA
4
TRB Advisors
New York
$8.75M +$9.34M +18,333 New
AI
5
Aperture Investors
New York
$7.47M +$7.97M +15,653 New
SAM
6
Sectoral Asset Management
Quebec, Canada
$6.3M +$6.62M +13,000 New
MP
7
MSD Partners
New York
$6.28M +$6.6M +12,956 New
FCM
8
Farallon Capital Management
California
$6.21M +$6.62M +13,000 New
Millennium Management
9
Millennium Management
New York
$3.28M +$3.5M +6,877 New
PVI
10
Pura Vida Investments
New York
$2.58M +$2.72M +5,333 New
BlackRock
11
BlackRock
New York
$2.52M +$2.64M +5,189 New
HM
12
HealthCor Management
New York
$2.42M +$2.55M +5,000 New
IC
13
Ikarian Capital
Texas
$2.39M +$2.55M +5,000 New
SFM
14
Sphera Funds Management
Israel
$2.39M +$2.55M +5,000 New
Blackstone Inc
15
Blackstone Inc
New York
$2.02M +$2.12M +4,167 New
MIM
16
Monashee Investment Management
Massachusetts
$2.02M +$2.12M +4,167 New
WP
17
Woodline Partners
California
$1.93M +$2.03M +3,978 New
PCP
18
Proficio Capital Partners
Massachusetts
$1.8M +$1.89M +3,719 New
LCM
19
Laurion Capital Management
New York
$986K +$1.05M +2,067 New
Goldman Sachs
20
Goldman Sachs
New York
$955K +$1M +1,971 New
MWNA
21
Marshall Wace North America
New York
$753K +$804K +1,578 New
Alyeska Investment Group
22
Alyeska Investment Group
Illinois
$641K +$674K +1,323 New
Vanguard Group
23
Vanguard Group
Pennsylvania
$565K +$594K +1,167 New
Squarepoint
24
Squarepoint
New York
$485K +$509K +1,000 New
PCM
25
Pinz Capital Management
New York
$402K +$423K +830 New
1
2

FNCH Hedge Fund Activity: Q1 2021 in Review

36 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Finch Therapeutics Group, Inc. Common Stock (FNCH) for Q1 2021, worth a combined $109M.

Buyers outnumbered sellers: 36 funds opened new FNCH positions and 0 closed out — a net gain of 36 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Baupost Group, opening a new position worth an estimated $20.5M.

  • 36 institutional investors held Finch Therapeutics Group, Inc. Common Stock (FNCH) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $109M of Finch Therapeutics Group, Inc. Common Stock stock for Q1 2021.
  • 36 funds opened new Finch Therapeutics Group, Inc. Common Stock positions in Q1 2021 and 0 closed out, a net change of +36 holders.
  • The largest Finch Therapeutics Group, Inc. Common Stock buyer in Q1 2021 was Baupost Group, an estimated $20.5M added.

Based on aggregated 13F filings for Q1 2021.